Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 130

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome

Gunawardana, C. Geeth, Mehrabian, Mohadeseh, Wang, Xinzhu, Mueller, Iris, Lubambo, Isabela B., Jonkman, James E.N., Wang, Hansen, Schmitt-Ulms, Gerold·2015·Molecular & Cellular Proteomics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m115.050724

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 57

  1. Neve, 1986, Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2, Brain Res, 387, 271
  2. Weingarten, 1975, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. U.S.A, 72, 1858, 10.1073/pnas.72.5.1858 · DOI · Paper page
  3. Grundke-Iqbal, 1986, Microtubule-associated protein tau. A component of Alzheimer paired helical filaments, J. Biol. Chem, 261, 6084, 10.1016/S0021-9258(17)38495-8 · DOI
  4. Wolozin, 1986, A neuronal antigen in the brains of Alzheimer patients, Science, 232, 648, 10.1126/science.3083509 · DOI
  5. Harada, 1994, Altered microtubule organization in small-calibe axons of mice lacking tau protein, Nature, 369, 488, 10.1038/369488a0 · DOI
  6. Dawson, 2001, Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice, J. Cell Sci, 114, 1179, 10.1242/jcs.114.6.1179 · DOI · Paper page
  7. Brandt, 1995, Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain, J. Cell Biol, 131, 1327, 10.1083/jcb.131.5.1327 · DOI
  8. Farias, 2002, Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies, J. Cell. Biochem, 85, 315, 10.1002/jcb.10133 · DOI
  9. Ittner, 2010, Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models, Cell, 142, 387, 10.1016/j.cell.2010.06.036 · DOI · Paper page
  10. Ittner, 2011, Amyloid-beta and tau – a toxic pas de deux in Alzheimer's disease, Nat. Rev. Neurosci, 12, 65, 10.1038/nrn2967 · DOI · Paper page
  11. Hirokawa, 1988, Tau proteins: the molecular structure and mode of binding on microtubules, J. Cell Biol, 107, 1449, 10.1083/jcb.107.4.1449 · DOI
  12. Cleveland, 1977, Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly, J. Mol. Biol, 116, 227, 10.1016/0022-2836(77)90214-5 · DOI · Paper page
  13. Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U.S.A, 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
  14. Horiguchi, 2003, Nitration of tau protein is linked to neurodegeneration in tauopathies, Am. J. Pathol, 163, 1021, 10.1016/S0002-9440(10)63462-1 · DOI
  15. Wang, 2007, Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model, Proc. Natl. Acad. Sci. U.S.A, 104, 10252, 10.1073/pnas.0703676104 · DOI
  16. Arnaud, 2009, Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells, J. Neurochem, 110, 328, 10.1111/j.1471-4159.2009.06142.x · DOI
  17. Marcus, 2011, Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease, J. Neurogenet, 25, 127, 10.3109/01677063.2011.626471 · DOI
  18. Lee, 1998, Tau interacts with src-family nonreceptor tyrosine kinases, J. Cell Sci, 111, 3167, 10.1242/jcs.111.21.3167 · DOI
  19. Reynolds, 2008, Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases, J. Biol. Chem, 283, 18177, 10.1074/jbc.M709715200 · DOI
  20. Patterson, 2011, Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of pre-existing tau aggregates on fast axonal transport, Biochemistry, 50, 10300, 10.1021/bi2009147 · DOI
  21. Dou, 2003, Chaperones increase association of tau protein with microtubules, Proc. Natl. Acad. Sci. U.S.A, 100, 721, 10.1073/pnas.242720499 · DOI
  22. Strittmatter, 1994, Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A, 91, 11183, 10.1073/pnas.91.23.11183 · DOI · Paper page
  23. Chambraud, 2010, A role for FKBP52 in Tau protein function, Proc. Natl. Acad. Sci. U.S.A, 107, 2658, 10.1073/pnas.0914957107 · DOI · Paper page
  24. Qureshi, 2011, Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro, J. Biol. Chem, 286, 5055, 10.1074/jbc.M110.178905 · DOI
  25. Liu, 2012, PACSIN1, a Tau-interacting protein, regulates axonal elongation and branching by facilitating microtubule instability, J. Biol. Chem, 287, 39911, 10.1074/jbc.M112.403451 · DOI
  26. Kampers, 1996, RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments, FEBS Lett, 399, 344, 10.1016/S0014-5793(96)01386-5 · DOI · Paper page
  27. King, 2006, Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid, J. Cell Biol, 175, 541, 10.1083/jcb.200605187 · DOI
  28. Watts, 2009, Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones, PLoS Pathog, 5, e1000608, 10.1371/journal.ppat.1000608 · DOI
  29. Mehrabian, 2014, CRISPR-Cas9-based knockout of the prion protein and its effect on the proteome, PLoS One, 9, e114594, 10.1371/journal.pone.0114594 · DOI
  30. Zieske, 2006, A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies, J. Exp. Bot, 57, 1501, 10.1093/jxb/erj168 · DOI
  31. Sandberg, 2014, Quantitative accuracy in mass spectrometry based proteomics of complex samples: the impact of labeling and precursor interference, J. Proteomics, 96, 133, 10.1016/j.jprot.2013.10.035 · DOI
  32. Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. Royal Stat. Soc, 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
  33. Vizcaino, 2014, ProteomeXchange provides globally coordinated proteomics data submission and dissemination, Nat. Biotechnol, 32, 223, 10.1038/nbt.2839 · DOI
  34. Vizcaino, 2013, The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013, Nucleic Acids Res, 41, D1063, 10.1093/nar/gks1262 · DOI · Paper page
  35. Rothbauer, 2008, A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins, Mol. Cell. Proteomics, 7, 282, 10.1074/mcp.M700342-MCP200 · DOI
  36. Wang, 2006, The proline-rich domain and the microtubule binding domain of protein tau acting as RNA binding domains, Protein Pept. Lett, 13, 679, 10.2174/092986606777790566 · DOI
  37. Shaner, 2007, Advances in fluorescent protein technology, J. Cell Sci, 120, 4247, 10.1242/jcs.005801 · DOI
  38. Chaudhury, 2010, TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI, Nat. Cell Biol, 12, 286, 10.1038/ncb2029 · DOI · Paper page
  39. Zhang, 2013, Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models, J. Biol. Chem, 288, 22042, 10.1074/jbc.M112.436402 · DOI
  40. Portelius, 2008, Characterization of tau in cerebrospinal fluid using mass spectrometry, J. Proteome Res, 7, 2114, 10.1021/pr7008669 · DOI
  41. Schraen-Maschke, 2008, Tau as a biomarker of neurodegenerative diseases, Biomark. Med, 2, 363, 10.2217/17520363.2.4.363 · DOI
  42. Kozielski, 2011, Proteome analysis of microtubule-associated proteins and their interacting partners from mammalian brain, Amino Acids, 41, 363, 10.1007/s00726-010-0649-5 · DOI
  43. Rudrabhatla, 2011, Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs, Faseb J, 25, 3896, 10.1096/fj.11-181297 · DOI · Paper page
  44. Thompson, 2012, Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation, ACS Chem. Biol, 7, 1677, 10.1021/cb3002599 · DOI
  45. King, 2012, The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease, Brain Res, 1462, 61, 10.1016/j.brainres.2012.01.016 · DOI
  46. Leverenz, 2007, A novel progranulin mutation associated with variable clinical presentation and tau, TDP43, and alpha-synuclein pathology, Brain, 130, 1360, 10.1093/brain/awm069 · DOI · Paper page
  47. Li, 1998, The 77-kDa echinoderm microtubule-associated protein (EMAP) shares epitopes with the mammalian brain MAPs, MAP-2, and tau, Biochem. Biophys. Res. Commun, 250, 502, 10.1006/bbrc.1998.9271 · DOI
  48. Suprenant, 1993, EMAP, an echinoderm microtubule-associated protein found in microtubule-ribosome complexes, J. Cell Sci, 104, 445, 10.1242/jcs.104.2.445 · DOI
  49. Nelson, 1993, Alz-50 immunohistochemistry in the normal sheep striatum: a light and electron microscope study, Brain Res, 600, 285, 10.1016/0006-8993(93)91385-6 · DOI
  50. Papasozomenos, 1989, Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications, Lab. Invest, 60, 123
  51. Papasozomenos, 1989, Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments, Lab. Invest, 60, 375
  52. Iseki, 2001, Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells, Acta Neuropathol, 102, 285, 10.1007/s004010000333 · DOI · Paper page
  53. Perreault, 2009, Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau, J. Neuropathol. Exp. Neurol, 68, 503, 10.1097/NEN.0b013e3181a1fc49 · DOI · Paper page
  54. Benussi, 2005, Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation, Exp. Cell Res, 308, 78, 10.1016/j.yexcr.2005.04.021 · DOI
  55. Lewis, 2000, Neurofibrillary tangles, amyotrophy, and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat. Genet, 25, 402, 10.1038/78078 · DOI · Paper page
  56. Smith, 1995, Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells, FEBS Lett, 375, 243, 10.1016/0014-5793(95)01221-Y · DOI
  57. Terwel, 2005, Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice, J. Biol. Chem, 280, 3963, 10.1074/jbc.M409876200 · DOI

Cited by

Metadata

Authors
Gunawardana, C. G., Mehrabian, M., Wang, X., Mueller, I., Lubambo, I. B., Jonkman, J. E. N., Wang, H., & Schmitt-Ulms, G.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2015-11
Volume
14
Issue
11
Pages
3000-3014
ISSN
1535-9476
Cited by
130
References
17
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.